Kentucky · 2026 Regular Session · Bill

HB 263: AN ACT relating to undesignated glucagon.

In committee Last action January 15, 2026: to Health Services (H)

Plain-language summary

HB 263 is a bill introduced in the Kentucky House on January 8, 2026. According to its official title, it concerns: AN ACT relating to undesignated glucagon. Primary sponsor: Matt Lehman (Democratic), Adam Moore (Democratic). Most recent recorded action (January 15, 2026): to Health Services (H).

Sponsors

Primary sponsors: Matt Lehman (Democratic); Adam Moore (Democratic).